All News #Library
Biotech
Immvira Reveals High Response In BCG-Unresponsive Bladder Cancer
04 Dec 2025 //
PR NEWSWIRE
ImmVira Doses First Patient in Ph2 NMIBC Trial
10 Jun 2025 //
PR NEWSWIRE
ImmVira Presents Clinical Result of MVR-C5252 at 2025 AACR Meeting
27 Apr 2025 //
PR NEWSWIRE
ImmVira`s MVR-T3011 IT Injection Receives FDA Fast Track Designation
15 Mar 2024 //
PR NEWSWIRE
MVR-T3011 IV Successfully Concludes Phase I Clinical Study
09 Nov 2023 //
PR NEWSWIRE

Market Place
Sourcing Support